— Know what they know.
Not Investment Advice

GTS NYSE

Triple-S Management Corporation
1W: +0.9% 1M: +0.9% 3M: +2.0% 1Y: +52.9% 3Y: +78.5% 5Y: +89.2%
$35.99
Last traded 2022-01-31 — delisted
NYSE · Healthcare · Medical - Healthcare Plans

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$3.7B +9.7% ▲
5Y CAGR: +5.0%
Gross Profit
$3.7B +9.7% ▲
5Y CAGR: +5.0%
Operating Income
$5M -96.4% ▼
5Y CAGR: -38.6%
Net Income
$67M -27.7% ▼
5Y CAGR: +5.2%
EPS (Diluted)
$2.88 -27.5% ▼
5Y CAGR: +8.4%
EBITDA
$114M -26.1% ▼
5Y CAGR: +6.9%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2016FY2017FY2018FY2019FY2020
Revenue$3.0B$2.9B$3.0B$3.4B$3.7B
YoY Growth+2.8%-2.3%+2.7%+12.7%+9.7%
Cost of Revenue$0$0$0$0$0
Gross Profit$3.0B$2.9B$3.0B$3.4B$3.7B
Gross Margin100.0%100.0%100.0%100.0%100.0%
R&D Expenses$0$0$0$0$0
SG&A Expenses$494M$477M$555M$569M$656M
Operating Expenses$3.0B$2.8B$3.1B$3.2B$3.6B
Operating Income$11M$86M-$86M$140M$5M
Operating Margin0.4%2.9%-2.9%4.1%0.1%
Interest Expense$8M$7M$7M$8M$8M
Income Before Tax$11M$79M-$93M$132M$92M
Tax Expense-$6M$24M-$30M$39M$25M
Net Income$17M$54M-$63M$93M$67M
Net Margin0.6%1.9%-2.1%2.8%1.8%
EPS (Diluted)$0.68$2.15$-2.62$3.97$2.88
EBITDA$33M$99M-$73M$175M$114M
Shares Outstanding26M25M24M23M23M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms